Trial Profile
A multicenter, retrospective, cohort study to evaluate the efficacy and safety of rituximab and glucocorticoid therapy for induction of remission in patients with severe renal disease in ANCA-negative and ANCA-positive small vessel vasculitis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Glucocorticoids
- Indications Renal failure
- Focus Therapeutic Use
- 10 May 2016 New trial record